Study of Paclitaxel in Patients With Ovarian Cancer

Clinical trial NCT00989131 · COMPLETED

Trial details

NCT number: NCT00989131
Sponsor: Oasmia Pharmaceutical AB
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer

Start date: 2009-02-01
Primary completion: 2013-10-01
Enrollment: 789

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.